FDA Announces Five Companies Are Recalling Diabetes Drugs Over Carcinogen Concerns

Two weeks after announcing concerns about high-levels of carcinogens in popular diabetes drugs, the U.S. Food and Drug Administration (FDA) announced the first voluntary recalls of this class of drugs manufactured by five companies.

On Thursday, the FDA said Apotex, Amneal, Marksans, Lupin and Teva have announced recalls of some lots of extended-release metformin medications due to the presence of N-nitrosodimethylamine (NDMA) levels above the acceptable daily intake levels established by the regulatory agency.